Sentences with phrase «leading cancer researchers»

These advisory boards, which include leading cancer researchers and cancer research advocates, meet regularly throughout the year to review the status and progress of NCI's intramural and extramural programs.

NEW ORLEANS — Vice President Biden called on the nation's leading cancer researchers to accelerate progress in the fight against the disease by sharply boosting collaborations and data sharing and by giving him advice on how to make the federal government a forceful ally in the anti-cancer effort.

According to Robert Weinberg, a leading cancer researcher and founding member of the Whitehead Institute in Cambridge, Massachusetts, a number of «built - in native defenses» usually prevent the development of cancer.

Still, the frustrations in creating a consistently effective immunotherapy led one leading cancer researcher to refer this month to the «precision oncology illusion.»

Not exact matches

But researchers at the University of Aberdeen found that a treatment originally designed for fighting cancer and diabetes could melt away fatty arterial plaque with a single dosing and reverse the effects of atherosclerosis, which can lead to multiple heart problems.

When three researchers asked 12 breast cancer patients from central Mexico, for instance, what each did right after discovering a lump in her breast, the women's answers revealed a dozen different health care routes — paths that led, in some cases, to markedly different outcomes.

On any given day, Canada's leading researchers unravel the mysteries of biology in state - of - the - art labs throughout the Toronto Medical Discovery Tower and the Ontario Institute for Cancer Research; early - stage science and technology companies put business plans into action in the MaRS Incubator; organizations across the innovation spectrum grow their businesses in the Heritage Building — the original brick façade of the old Toronto General Hospital.

Over the past two decades, Dr. Bear, a researcher and surgeon, has led international trials that have resulted in major changes in the treatment of breast cancer and dramatically increased the chance for breast conservation among women with breast cancer.

If you are a cancer researcher, has your research led you to believe that a deity is responsible?

Professor Stephen Duffy, lead researcher and Cancer Research UK's professor of cancer screening, said: «The results of our study showed that the NHS breast cancer screening programme has been even more effective at saving lives than we predCancer Research UK's professor of cancer screening, said: «The results of our study showed that the NHS breast cancer screening programme has been even more effective at saving lives than we predcancer screening, said: «The results of our study showed that the NHS breast cancer screening programme has been even more effective at saving lives than we predcancer screening programme has been even more effective at saving lives than we predicted.

Over the years, Roswell Park has also become recognized as one of the United States» leading cancer treatment and research centers, and it recruits physicians and researchers from across the world to come live and work in the Buffalo area.

The researchers used a drug called clorgyline to inhibit the activity of the MAOA enzyme; the drug disrupted the signaling system that led to cancer cell invasion and proliferation.

During this in depth study, an international team of researchers led by British scientists investigated the impact of anti-hormone therapy on samples taken from patients with prostate cancer.

If researchers could decrease the side - effects of liposome use, doctors could use higher doses of these drugs, perhaps leading to better cancer control.

Dr. Greenbaum and Dr. Łksza also played an integral role in a companion piece of research led by researchers Vinod P. Balachandran, MD, Taha Merghoub, PhD, and Steven D. Leach, MD, at Memorial Sloan Kettering Cancer Center (MSK) that was also published in Nature today.

Professor Jose Valderas, one of the lead researchers from the University of Exeter Medical School, said: «When you're trying to diagnose cancer, other illnesses can be a distraction either because they also require attention or because they can mask what would otherwise be flagged as a possible sign of cancer.

By studying human cancer cells and animal models of cancer in the lab, our researchers have shown that loss of PTEN leads to high levels of PI (3,4) P2, which could result in hyperactivation of AKT.

Led by researchers at the University of Pittsburgh School of Medicine, an international panel of pathologists and clinicians has reclassified a type of thyroid cancer to reflect that it is noninvasive and has a low risk of recurrence.

Cervical cancer rates in the United States are higher than previously believed, particularly among 65 - to 69 - year - old women and African - American women, according to a study led by a researcher at the University of Maryland School of Medicine published in the journal Ccancer rates in the United States are higher than previously believed, particularly among 65 - to 69 - year - old women and African - American women, according to a study led by a researcher at the University of Maryland School of Medicine published in the journal CancerCancer.

The drug was developed by Lawrence - based CritiTech, and the drug - testing and phase I clinical trial were conducted by KU Cancer Center researchers, led by Stephen Williamson, M.D., medical director of Cancer Clinical Trials.

Researchers led by Patricia Donahoe and Xiaolong Wei of Massachusetts General Hospital and Harvard Medical School found that the common chemotherapy agent doxorubicin actually encourages the growth of ovarian cancer stem cells.

The researchers, led by Dr Vinay Prasad at Oregon Health & Science University, say their findings «raise concern that the NCCN justifies the coverage of costly, toxic cancer drugs based on weak evidence.»

«Our corrected calculations show that women just past 65, when current guidelines state that screenings can stop for many women, have the highest rate of cervical cancer,» says the study's lead author, Anne F. Rositch, Ph.D., M.S.P.H., an assistant professor of epidemiology and public health at the University of Maryland School of Medicine and a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Ccancer,» says the study's lead author, Anne F. Rositch, Ph.D., M.S.P.H., an assistant professor of epidemiology and public health at the University of Maryland School of Medicine and a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer CCancer Center.

Led by Jean - Christophe Marine (VIB - KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin cancer.

Led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), the retrospective study suggested that a pattern of molecules called microRNA (miRNA) in tumor cells might predict patients» response to radiation therapy.

Institute researchers Dr Ashley Ng, Dr Maria Kauppi, Professor Warren Alexander, Professor Don Metcalf and colleagues from the institute's Cancer and Haematology and Molecular Medicine divisions led the research, published in the journal Proceedings of the National Academy of Sciences.

An experimental drug in early development for aggressive brain tumors can cross the blood - brain tumor barrier, kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).

In a study published in Clinical Gastroenterology and Hepatology, Saint Louis University researchers have found a link between acute pancreatitis (inflammation of the pancreas) and pancreatic cancer, a finding which may eventually lead to some pancreatic cancers being detected earlier.

Researchers at Roswell Park Cancer Institute (RPCI) have identified a mechanism of breast cancer cells that leads to chemotherapy resistance in inflammatory breast cCancer Institute (RPCI) have identified a mechanism of breast cancer cells that leads to chemotherapy resistance in inflammatory breast ccancer cells that leads to chemotherapy resistance in inflammatory breast cancercancer.

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingcancer that was at a low risk of coming back.

Researchers at the University of Calgary's Hotchkiss Brain Institute (HBI) have made a discovery that could lead to better treatment for patients suffering from brain cancer.

Led by associate professor of pathology and Yale Cancer Center member Don Nguyen, PhD, the researchers analyzed RNA from patients with disease that was limited to the lungs as well as cancers that had spread.

Led by post-doctoral fellows, Martina Absinta, Ph.D. and Seung - Kwon Ha, Ph.D., along with researchers from the National Cancer Institute, the team discovered lymphatic vessels in the dura, the leathery outer coating of the brain.

«This study forms the basis for future research in patients with breast cancer and offers hope for targeted therapy for patients with aggressive triple - negative inflammatory breast cancer,» said lead researcher Mateusz Opyrchal, M.D., Ph.D., Assistant Professor of Oncology at RPCI.

A new study led by UNC Lineberger Comprehensive Cancer Center researchers identifies distinct patterns of side effects that patients could use to guide their choices.

A comparison of these two cancers, published April 9 in the journal Cancer Cell, suggests that they are similar in origin, leading researchers at the University of Cambridge to believe that devils simply may be at greater risk for these kinds of diseases.

Lead researcher Professor Hemant Kocher from QMUL's Barts Cancer Institute said: «This is the first time that we have combined vitamin A with chemotherapy for pancreatic cCancer Institute said: «This is the first time that we have combined vitamin A with chemotherapy for pancreatic cancercancer.

This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone Health, and published online August 17 in the journal Cell.

«Colorectal cancer is the second most common cause of cancer deaths [after lung cancer] in the United States and is an enormous health problem around the world,» said the study's lead author, Robert J. Mayer, MD, faculty vice president for academic affairs, medical oncologist and colorectal cancer researcher at Dana - Farber.

Salk researcher Yao - Cheng Li and professor Geoffrey Wahl developed a new technology for visualizing protein interactions, which could lead to better cancer drugs.

The study was led by Dr. Alexandre Zlotta, Director of Uro - Oncology at Mount Sinai Hospital, and researcher with the Lunenfeld - Tanenbaum Research Institute, part of Sinai Health System in Toronto, Canada, and Dr. Paul Boutros, Principal Investigator, Informatics and Bio-computing, Ontario Institute for Cancer Research (OICR).

The recommendation for such a tightly defined surgical margin is the result of a study led by researchers at Perlmutter Cancer Center at NYU Langone Health and published online Oct. 2 in the Journal of the American Academy of Dermatology.

The first author of the Science paper is Laura Gaydos, a graduate student in Strome's lab at UC Santa Cruz who led the study for her Ph.D. thesis and is now a postdoctoral researcher at Fred Hutchinson Cancer Research Center in Seattle.

Gay and bisexual men were up to six times more likely than heterosexual men to take part in indoor tanning, and twice as likely to report a history of skin cancer, including nonmelanoma and melanoma, according to a study led by UC San Francisco researchers.

However, the researchers uncovered several mechanisms leading to tumor resistance, giving them insight into which drugs could combat the resistant cancer.

A study published in the Journal of Clinical Oncology in January of 2015 led by a Sunnybrook Health Sciences Centre researcher found that the likelihood of dying of other causes for a group of men with low - risk prostate cancer in the study was about nine times higher than the risk of dying from the prostate cancer.

Several years ago, for example, poor chemical probe data led researchers to pursue a final stage clinical trial on a cancer drug candidate called iniparib.

Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I / II clinical trial as early as Spring 2015.

«After years of collaboration with some of the world's leading prostate cancer researchers and medical institutions who have studied the scientific and clinical benefits of phi, we are pleased that the test is now available to help physicians and patients with an elevated PSA test result, more accurately detect prostate cancer2,» said John Blackwood, senior vice president, Chemistry / Immunoassay Business Unit, Beckman Coulter Diagnostics.

A study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified an abnormal metabolic pathway that drives cancer - cell growth in a particular glioblastoma suCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified an abnormal metabolic pathway that drives cancer - cell growth in a particular glioblastoma suCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified an abnormal metabolic pathway that drives cancer - cell growth in a particular glioblastoma sucancer - cell growth in a particular glioblastoma subtype.